title: Cytomegalovirus infection in patients with haematological diseases and after autologous stem cell transplantation as consolidation: a single-centre study.
abstract: Because of the widespread use of immunosuppressive drugs, CMV infection is one of the most important causes of morbidity and mortality in patients with haematological malignancies worldwide. The aim of the study was to retrospectively analyse the epidemiology of CMV infection in haematological patients. Between 2008 and 2014, 1238 quantitative CMV DNA detections from plasma specimens were performed. These specimens were collected from 271 patients with haematological malignancy. Patients were grouped on the basis of underlying diseases (lymphoid and myeloid malignancies and other haematological diseases). In the lymphoid and myeloid groups, we distinguished ASCT and non-ASCT groups. During the studied period, the majority of examined patients (82.6 %) were treated with lymphoproliferative disease. A total of 126 (46.5 %) patients underwent ASCT, while 145 (53.5 %) did not have stem cell transplantation. A total of 118 (9.5 %) of 1238 plasma specimens proved to be positive for CMV DNA; these specimens were collected from 66 (24.4 %) patients. Twenty-four (16.6 %) of 145 non-ASCT patients had CMV PCR positive specimens. Among non-ASCT patients with positive CMV PCR results, 10 patients were asymptomatic, 14 had symptomatic reactivation, while 2 had CMV disease. In the ASCT group, 42 (33.3 %) patients had CMV PCR positive samples. CMV reactivation was asymptomatic in 34 (81 %) cases, and 8 (19 %) patients had symptomatic reactivation. In the non-ASCT group, the rate of CMV infection is low. In the ASCT group, the prevalence of CMV infection was higher than in the non-ASCT group, but the majority of CMV infection was asymptomatic and only small number of patients had symptomatic reactivation. Thus, our results also showed that the use of routine CMV DNA monitoring is not necessary in patients with haematological malignancies not receiving fludarabine-containing regimen or alemtuzumab, in spite of this to decrease the mortality we have to consider the use of molecular tests in case of suspected infectious conditions.
authors.affiliation: Department of Hematology, Second Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.
authors.forename: Klára
authors.initials: K
authors.lastname: Piukovics
authors.affiliation: Institute of Clinical Microbiology, University of Szeged, Semmelweis street 6, Szeged, H-6725, Hungary.
authors.forename: Gabriella
authors.initials: G
authors.lastname: Terhes
authors.affiliation: Department of Hematology, Second Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.
authors.forename: Tímea
authors.initials: T
authors.lastname: Gurbity-Pálfi
authors.affiliation: Department of Hematology, Second Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.
authors.forename: Ágnes
authors.initials: Á
authors.lastname: Bereczki
authors.affiliation: Department of Medical Physics and Informatics, University of Szeged, Szeged, Hungary.
authors.forename: Ferenc
authors.initials: F
authors.lastname: Rárosi
authors.affiliation: Institute of Clinical Microbiology, University of Szeged, Semmelweis street 6, Szeged, H-6725, Hungary.
authors.forename: Judit
authors.initials: J
authors.lastname: Deák
authors.affiliation: Department of Hematology, Second Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.
authors.forename: Zita
authors.initials: Z
authors.lastname: Borbényi
authors.affiliation: Institute of Clinical Microbiology, University of Szeged, Semmelweis street 6, Szeged, H-6725, Hungary. urban.edit@med.u-szeged.hu.
authors.forename: Edit
authors.initials: E
authors.lastname: Urbán
mesh_terms: D000328:Adult; D000368:Aged; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy*; D005260:Female; D006402:Hematologic Diseases / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000639:trends; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D014182:Transplantation, Autologous / Q000639:trends
keywords: Cytomegalovirus; Diagnosis; Immunocompromised; Molecular